您的位置: 首页 > 农业专利 > 详情页

New anti-human igbeta antibody
专利权人:
Astellas Pharma Inc.
发明人:
Yamajuku, Daisuke,Seki, Mutsumi,Honda, Takashi,Kubo, Satoshi,Soga, Shinji,Morinaka, Akifumi
申请号:
AU2015300080
公开号:
AU2015300080A1
申请日:
2015.08.05
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
[Problem] To provide an anti-human Igβ antibody in which BCR and FcγRIIb are crosslinked and which has a more enhanced immunosuppressive function compared to conventional antibodies. [Solution] An anti-human Igβ antibody including: a heavy-chain variable region that includes a CDR 1 comprising an amino acid sequence from amino acid numbers 31-35 of SEQ ID NO: 2, a CDR 2 comprising an amino acid sequence from amino acid numbers 50-65 of SEQ ID NO: 2, and a CDR 3 comprising an amino acid sequence from amino acid numbers 98-108 of SEQ ID NO: 2; a light-chain variable region that includes a CDR 1 comprising an amino acid sequence from amino acid numbers 24-38 of SEQ ID NO: 4, a CDR 2 comprising an amino acid sequence from amino acid numbers 54-60 of SEQ ID NO: 4, and a CDR 3 comprising an animo acid sequence from amino acid numbers 93-101 of SEQ ID NO: 4; and a heavy-chain constant region, said region being a human Igγ1 constant region having S239D, H268D, and L328W amino acid variations.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充